Consistent with a MIF-dependent inhibition of antigen presentation, co-culture of purified CD8+ T cells with MIF-treated, tumor antigen-pulsed DCs reduced the ability of CD8+ to lyse tumor cells (104). The gene discussed is CD8A; the disease is neoplasm.